Enteroaggregative E.Coli (EAEC)

NCT00362869 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

NIH

Sponsor class

Conditions

Escherichia Coli Infections

Interventions

DRUG: Levofloxacin
DRUG: Placebo
BIOLOGICAL: Enteroaggregative E. coli (EAEC)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)